Courtney Jones

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

Amy Langdon, Drew J. Schwartz, Christopher Bulow et al. · Genome Medicine · 2021 · 90 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection

Erik R. Dubberke, Kathleen M. Mullane, Dale N. Gerding et al. · Open Forum Infectious Diseases · 2016 · 76 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic

Ken Blount, William D. Shannon, Elena Deych et al. · Open Forum Infectious Diseases · 2019 · 70 citations · Full text

Life Sciences, Biostatistics, Microbiology +17

Impact of investigational microbiota therapeutic RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial

Suryang Kwak, JooHee Choi, Tiffany Hink et al. · Microbiome · 2020 · 63 citations · Full text

Life Sciences, Infectious Diseases, Medical Microbiology +16

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent <i>Clostridioides difficile</i> Infections

Sahil Khanna, Darrell S. Pardi, Courtney Jones et al. · Clinical Infectious Diseases · 2020 · 53 citations · Full text

Life Sciences, Microbiology, Pharmacology +14